// App-Quantinova.ai

TCT-404 : Benefit and Risks of Aspirin on Top of Ticagrelor in Acute Coronary Syndromes: Insights From the Randomized GLOBAL LEADERS Trial

Researchers

Presenter

  • Mariusz Tomaniak

Principal Investigators

  • Yoshinobu Onuma

  • Efthymios Deliargyris

  • Kuniaki Takahashi

  • Norihiro Kogame

  • Rodrigo Modolo

  • Chun-Chin Chang

  • Tessa Rademaker-Havinga

  • Robert Storey

  • George Dangas

  • Deepak Bhatt

  • Dominick Angiolillo

  • Christian Hamm

  • Marco Valgimigli

  • Stephan Windecker

  • Philippe Gabriel Steg

  • Pascal Vranckx

  • Patrick Serruys

Medical Centers

  • Thorax Centre, Erasmus MC, Department of Interventional Cardiology, Rotterdam, Netherlands

  • Kerckhoff Clinic, Bad Nauheim, Germany

  • Brigham and Women's Hospital, Boston, Massachusetts

  • Mount Sinai Medical Center, New York, New York

  • Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands

  • Groupe Hospitalier Bichat – Claude-Bernard, Paris, France

  • Imperial College, Rotterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • University of Sheffield, Sheffield, United Kingdom

  • Swiss Cardiovascular Center, Inselpsital, Bern, Switzerland

  • University of Florida-Shands, Jacksonville, Florida

  • Medical University of Warsaw, 1st Department of Cardiology, Warsaw, Poland

  • Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland

  • Hartcentre Hasselt, Hasselt, Belgium

  • Cardialysis, Rotterdam, Netherlands

Locations

  • Netherlands

  • United States

  • United Kingdom

  • Switzerland

  • Germany

  • France

  • Poland

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Stable coronary artery disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Myocardial infarction

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved